Should You Follow the Better-Hearing Ear for Congenital Cytomegalovirus Infection and Isolated Sensorineural Hearing Loss?


Journal

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 9 10 2019
medline: 24 4 2020
entrez: 9 10 2019
Statut: ppublish

Résumé

To describe the progression of sensorineural hearing loss (SNHL) in the better- and poorer-hearing ears in children with asymptomatic congenital cytomegalovirus (CMV) infection with isolated SNHL. Longitudinal prospective cohort study. Tertiary medical center. We analyzed hearing thresholds of the better- and poorer-hearing ears of 16 CMV-infected patients with isolated congenital/early-onset or delayed-onset SNHL identified through hospital-based CMV screening of >30,000 newborns from 1982 to 1992. By 12 months of age, 4 of 7 patients with congenital/early-onset SNHL developed worsening thresholds in the poorer-hearing ear, and 1 had an improvement in the better-hearing ear. By 18 years of age, all 7 patients had worsening thresholds in the poorer-hearing ear and 3 patients had worsening thresholds in the better-hearing ear. Hearing loss first worsened at a mean age of 2 and 6 years in the poorer- and better-hearing ears, respectively. Nine patients were diagnosed with delayed-onset SNHL (mean age of 9 years vs 12 years for the poorer- and better-hearing ears), 6 of whom had worsening thresholds in the poorer-hearing ear and 1 in both ears. In most children with congenital CMV infection and isolated SNHL, the poorer-hearing ear worsened earlier and more precipitously than the better-hearing ear. This study suggests that monitoring individual hearing thresholds in both ears is important for appropriate interventions and future evaluation of efficacy of antiviral treatment.

Identifiants

pubmed: 31593522
doi: 10.1177/0194599819880348
pmc: PMC7274837
mid: NIHMS1590221
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

114-120

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Organisme : NIDCD NIH HHS
ID : U01 DC014706
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR025764
Pays : United States

Références

Pediatrics. 2008 Jun;121(6):1119-26
pubmed: 18519481
N Engl J Med. 2015 Mar 5;372(10):933-43
pubmed: 25738669
Ear Hear. 1995 Aug;16(4):361-71
pubmed: 8549892
PLoS One. 2013;8(3):e59624
pubmed: 23555729
J Pediatr. 2003 Jul;143(1):16-25
pubmed: 12915819
Pediatrics. 2017 Mar;139(3):
pubmed: 28209771
Arch Dis Child Fetal Neonatal Ed. 2017 Nov;102(6):F519-F524
pubmed: 28468898
J Pediatr. 2018 Sep;200:196-201.e1
pubmed: 29784513
BMJ Open. 2017 Jan 20;7(1):e013810
pubmed: 28110288
Otolaryngol Head Neck Surg. 2018 Apr;158(4):736-744
pubmed: 29557247
Am J Audiol. 2005 Dec;14(2):S200-16
pubmed: 16489864
J Clin Virol. 2008 Feb;41(2):57-62
pubmed: 17959414
Ir Med J. 2017 Dec 18;110(10):651
pubmed: 29465841
J Clin Virol. 2006 Feb;35(2):221-5
pubmed: 16384744
J Clin Virol. 2018 May;102:110-115
pubmed: 29571077
Pediatrics. 2017 Feb;139(2):
pubmed: 28119425
Rev Med Virol. 2007 Sep-Oct;17(5):355-63
pubmed: 17542052
Arch Dis Child Fetal Neonatal Ed. 2014 May;99(3):F230-6
pubmed: 24596404
Lancet Infect Dis. 2017 Jun;17(6):e177-e188
pubmed: 28291720
Early Hum Dev. 2011 Nov;87(11):723-8
pubmed: 21962770
Pediatrics. 2014 Nov;134(5):972-82
pubmed: 25349318
Arch Otolaryngol Head Neck Surg. 2010 Oct;136(10):999-1004
pubmed: 20956747
N Engl J Med. 2016 Sep 1;375(9):861-70
pubmed: 27579636
J Am Acad Audiol. 2000 May;11(5):283-90
pubmed: 10821506
Pediatrics. 2008 May;121(5):970-5
pubmed: 18450901
J Pediatr. 1999 Jul;135(1):60-4
pubmed: 10393605

Auteurs

Vanessa Torrecillas (V)

Division of Otolaryngology-Head and Neck Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.

Chelsea M Allen (CM)

Department of Population Health Sciences, Division of Biostatistics, University of Utah School of Medicine, Salt Lake City, Utah, USA.

Tom Greene (T)

Department of Population Health Sciences, Division of Biostatistics, University of Utah School of Medicine, Salt Lake City, Utah, USA.

Albert Park (A)

Division of Otolaryngology-Head and Neck Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.

Winnie Chung (W)

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Tatiana M Lanzieri (TM)

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Gail Demmler-Harrison (G)

Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH